Adams GC, Devlin JE, Klontz E, Laing RA, Branda JA. Development of a Combined Clinical and Research-Developed Testing Strategy for Highly Pathogenic Avian Influenza A Virus H5. Open Forum Infect Dis. 2025 Dec 10;13(1):ofaf744
Highly pathogenic avian influenza A (H5) virus continues to spread in animals with ongoing concern for potential human transmission. We describe an adaptable H5 screening approach that integrates clinical laboratory workflows with research-developed assays. This strategy efficiently screened thousands of samples, providing a practical and scalable model for H5 surveillance.
See Also:
Latest articles in those days:
- [preprint]Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza season 13 hours ago
- Epitope specificity shapes the CD4+ T cell response to influenza virus infection in mice 13 hours ago
- Vaccination against H5 HP avian influenza virus leads to persistent immune response in wild king penguins 1 days ago
- Molecular Epidemiology and Genetic Diversity of Influenza B Viruses Based on Whole-Genome Analysis in Japan and Myanmar, 2016-2020 1 days ago
- Assessing HPAI-H5 transmission risk across wild bird migratory flyways in the United States 1 days ago
[Go Top] [Close Window]
